David Ribes
Overview
Explore the profile of David Ribes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1595
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perier T, Renaudineau Y, Pellegrini J, Colombat M, Ramirez A, Guy P, et al.
Clin Kidney J
. 2025 Mar;
18(3):sfaf009.
PMID: 40052170
Background: Acute interstitial nephritis (AIN) is the most common renal immune-related adverse event after immune check-point inhibitors (ICI). We hypothesized that alternatively activated macrophages (CD163-M) could be involved in ICI-AIN...
2.
Colliou E, Ribes A, Gaible C, Marlas M, Ribes D, Labadens I, et al.
Res Pract Thromb Haemost
. 2025 Feb;
9(1):102687.
PMID: 39995752
Background: Congenital thrombotic thrombocytopenic purpura (cTTP) related to ADAMTS-13 deficiency is associated with a maternal risk of death of 10% and a risk of fetal loss greater than 50% without...
3.
Carle C, Fortenfant F, Bost C, Belliere J, Faguer S, Chauveau D, et al.
J Transl Autoimmun
. 2025 Feb;
10:100274.
PMID: 39917317
Objective: The autoimmune response to chromatin (Chr) or one of the nucleosome components (double stranded (ds)DNA and histones) is typically associated with the development of systemic lupus erythematosus (SLE). Related...
4.
Gauckler P, Matyjek A, Kapsia S, Marinaki S, Quintana L, Diaz M, et al.
J Am Soc Nephrol
. 2024 Oct;
PMID: 39431468
No abstract available.
5.
Renaudineau Y, Chauveau D, Faguer S, Huart A, Ribes D, Pugnet G, et al.
J Transl Autoimmun
. 2024 Jul;
9:100244.
PMID: 39021518
Lupus nephritis (LN) diagnosis and follow-up requires noninvasive biomarkers. Therefore, the added value of coupling the urinary soluble (s)CD163/creatinuria ratio with serological markers was evaluated in a real-world clinical practice....
6.
Gabilan C, Belliere J, Moranne O, Pfirmann P, Samson M, Delattre V, et al.
Rheumatology (Oxford)
. 2024 Jul;
PMID: 39001799
Objectives: Avacopan, a selective C5aR1 inhibitor, recently emerged as a glucocorticoid (GCs) sparing agent in ANCA-associated vasculitis (AAV). We aim to evaluate the tolerance and efficacy of avacopan given outside...
7.
Cassard A, Kounde C, Bouillet L, Goulenok T, Ribes D, Mesbah R, et al.
J Transl Autoimmun
. 2023 Oct;
7:100217.
PMID: 37877133
Introduction: Complement activation emerged as a key actor of anti-neutrophil cytoplasmic antibodies-associated vasculitis (AAV). Whether serum levels of C3 (sC3) or C3 kidney deposition may help to refine the prognosis...
8.
Benyahia R, Lazareth H, Flahault A, Brglez V, Seitz-Polski B, El Fil S, et al.
Kidney Int Rep
. 2023 Sep;
8(9):1892-1898.
PMID: 37705909
No abstract available.
9.
Meuleman M, Vieira-Martins P, El Sissy C, Audard V, Baudouin V, Bertrand D, et al.
Clin J Am Soc Nephrol
. 2023 Aug;
18(11):1435-1445.
PMID: 37615951
Background: C3 glomerulopathy and idiopathic immunoglobulin-mediated membranoproliferative GN (Ig-MPGN) are rare complement-mediated kidney diseases. Inherited forms of C3 glomerulopathy/Ig-MPGN are rarely described. Methods: Three hundred ninety-eight patients with C3 glomerulopathy...
10.
Salhi S, Ribes D, Fortenfant F, Faguer S
Nephrol Dial Transplant
. 2023 Jul;
38(12):2851-2853.
PMID: 37401153
No abstract available.